Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial
Rongmeng Jiang(Capital Medical University), Qingrong Nie(Tang Hospital), Bing Xue(Beijing Chuiyangliu Hospital), Meihua Song(Capital Medical University), Erming Zhang(Peking University Shougang Hospital), Shuwen Dong(Chinese Academy of Geological Sciences), Xuefeng Han(Tang Hospital), Chen Jin(Duke University), Zuoqing Zhang(Beijing Shijingshan Hospital), Xiuhong Jin(Beijing Anding Hospital), Baozeng Wang(Beijing Institute of Education), Jiandong Li(North China University of Science and Technology), Xiaoguang Li(AbbVie (United States)), Bing Han(Qingdao University), Yanyan Ding(Beijing Hospital), Jie Zhang(Tongji University), Yongxiang Zhang, Changhong Zhang(Beijing Shijingshan Hospital), Jing Zhu(Zhejiang Chinese Medical University), Xingwang Li(Beijing Ditan Hospital), Weian Guo(Peking University Shougang Hospital), Jianhua Liu(Zhejiang University of Science and Technology), Xiaoyin Shan(University of Pennsylvania)
Cited by 16
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
|New England Journal of Medicine|2009|603